Overview

Buprenorphine Disposition and CYP3A

Status:
Completed
Trial end date:
2014-03-29
Target enrollment:
Participant gender:
Summary
To evaluate role of CYP3A in buprenorphine disposition and effect
Phase:
N/A
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Buprenorphine
Ketoconazole
Rifampin